For the treatment of melanoma, hydroartemisinin could significantly reduce the levels of p-STAT3, p65, and IL-10 induced the p-STAT1 both in vitro and in vivo, indicating that dihydroartemisinin exhibits anticancer effects on melanoma by affecting STAT1/STAT3 pathway [59,60]. The gene discussed is STAT3; the disease is melanoma.